Polygenic risk scores are significantly less predictive of opioid dependence risk than environmental factors—in particular, education level and annual household income, according to new study results.
The findings indicate that genetic assays intended to predict individual risk for opioid use disorder—such as the AvertD test, developed by AutoGenomics Inc. and recently approved by the FDA—are premature and should be viewed with skepticism, and that the interplay between